Volume 133, Issue 6, Pages (December 2007)

Slides:



Advertisements
Similar presentations
Genetic Inactivation of RelA/p65 Sensitizes Adult Mouse Hepatocytes to TNF-induced Apoptosis In Vivo and In Vitro  Fabian Geisler, Hana Algül, Stephan.
Advertisements

The BH3-Only Protein Bid Does Not Mediate Death-Receptor-Induced Liver Injury in Obstructive Cholestasis  Padmavathi devi Nalapareddy, Sven Schüngel,
Volume 125, Issue 1, Pages (July 2003)
Volume 142, Issue 4, Pages (April 2012)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 135, Issue 5, Pages (November 2008)
Volume 133, Issue 2, Pages (August 2007)
Liver Fibrosis Protects Mice From Acute Hepatocellular Injury
Volume 129, Issue 2, Pages (August 2005)
Volume 143, Issue 5, Pages e1 (November 2012)
Volume 126, Issue 2, Pages (February 2004)
Volume 131, Issue 3, Pages (September 2006)
Volume 137, Issue 1, Pages e4 (July 2009)
Volume 134, Issue 7, Pages (June 2008)
Genetic Inactivation of RelA/p65 Sensitizes Adult Mouse Hepatocytes to TNF-induced Apoptosis In Vivo and In Vitro  Fabian Geisler, Hana Algül, Stephan.
Volume 127, Issue 4, Pages (October 2004)
Volume 132, Issue 4, Pages (April 2007)
Volume 136, Issue 3, Pages e2 (March 2009)
Volume 136, Issue 5, Pages (May 2009)
Volume 136, Issue 7, Pages e1 (June 2009)
Volume 127, Issue 5, Pages (November 2004)
Volume 146, Issue 5, Pages e1 (May 2014)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 125, Issue 6, Pages (December 2003)
Volume 138, Issue 7, Pages e7 (June 2010)
Volume 123, Issue 4, Pages (October 2002)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 119, Issue 2, Pages (August 2000)
Liver Fibrosis Protects Mice From Acute Hepatocellular Injury
Volume 129, Issue 1, Pages (July 2005)
Volume 129, Issue 2, Pages (August 2005)
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
Volume 42, Issue 4, Pages (April 2005)
Volume 143, Issue 3, Pages e3 (September 2012)
Volume 139, Issue 4, Pages e8 (October 2010)
Volume 133, Issue 1, Pages (July 2007)
Volume 63, Issue 3, Pages (September 2015)
Volume 142, Issue 4, Pages (April 2012)
Volume 132, Issue 7, Pages (June 2007)
Volume 127, Issue 3, Pages (September 2004)
Volume 136, Issue 4, Pages (April 2009)
Volume 146, Issue 7, Pages (June 2014)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 141, Issue 1, Pages (July 2011)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 117, Issue 4, Pages (October 1999)
Volume 129, Issue 2, Pages (August 2005)
Volume 135, Issue 5, Pages (November 2008)
Volume 135, Issue 2, Pages (August 2008)
Volume 134, Issue 4, Pages (April 2008)
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
Volume 133, Issue 4, Pages (October 2007)
Volume 139, Issue 2, Pages e1 (August 2010)
Volume 125, Issue 1, Pages (July 2003)
Volume 135, Issue 4, Pages (October 2008)
Volume 131, Issue 6, Pages (December 2006)
Volume 137, Issue 5, Pages (November 2009)
Volume 128, Issue 1, Pages (January 2005)
Volume 127, Issue 3, Pages (September 2004)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 128, Issue 4, Pages (April 2005)
Volume 125, Issue 1, Pages (July 2003)
Volume 141, Issue 3, Pages (September 2011)
Volume 144, Issue 5, Pages e4 (May 2013)
Volume 62, Pages S12-S22 (December 2002)
Volume 144, Issue 1, Pages (January 2013)
Amphiregulin: An early trigger of liver regeneration in mice
Volume 132, Issue 2, Pages (February 2007)
Volume 126, Issue 2, Pages (February 2004)
Volume 137, Issue 6, Pages e2 (December 2009)
Presentation transcript:

Volume 133, Issue 6, Pages 2019-2028 (December 2007) Bradykinin Attenuates Hepatocellular Damage and Fibrosis in Rats With Chronic Liver Injury  Pau Sancho–Bru, Ramón Bataller, Guillermo Fernandez–Varo, Montserrat Moreno, Leandra N. Ramalho, Jordi Colmenero, Montserrat Marí, Joan Clària, Wladimiro Jiménez, Vicente Arroyo, David A. Brenner, Pere Ginès  Gastroenterology  Volume 133, Issue 6, Pages 2019-2028 (December 2007) DOI: 10.1053/j.gastro.2007.09.023 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Expression of B1, B2, kininogen (kng), and kallikrein-1 (klk1). (A) Western blot analysis of B1 and B2 receptors in normal and cirrhotic human livers and in activated HSCs. Red ponceau staining was performed to ensure equal protein loading. Graphs show the densitometry quantification of Western blots. *P < .05 compared with normal tissue. ☐, Normal liver; ■, cirrhotic liver. (B) Gene expression analysis by quantitative reverse-transcription PCR of components of the KKS in human normal and cirrhotic livers as assessed by quantitative PCR. Gene expression is the mean of 6 different tissues. *P < .05 compared with normal tissue. ☐, Normal liver; ■, cirrhotic liver. (C) Gene expression analysis of components of the KKS in human quiescent and activated HSCs as assessed by quantitative PCR. *P < .05 compared with quiescent cells. ☐, Quiescent HSCs; ■, activated HSCs. (D) Gene expression analysis of components of the KKS in human hepatocytes as assessed by quantitative PCR. (E) Gene expression analysis of components of the KKS in human liver macrophages as assessed by quantitative PCR. Gastroenterology 2007 133, 2019-2028DOI: (10.1053/j.gastro.2007.09.023) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Effects of BK infusion on hepatocellular damage in CCl4-treated rats. (A) Representative photomicrograph of saline-infused control and CCl4-treated rat livers stained with B1- and B2-receptor antibodies. Magnification, 400×. (B) Effects of BK on ALT and AST serum levels. ANOVA, P < .01; ##P < .01 compared with control rats infused with saline. *P < .05 and **P < .01 compared with CCl4-treated rats infused with saline. BK was infused at 1 ng and 100 ng/kg/min. (C) Representative photomicrographs of liver specimens stained with H&E. Rats treated with CCl4 showed areas of intense hepatocellular necrosis, inflammation, hepatocyte ballooning, and apoptosis (arrows). Both 1 ng and 100 ng/kg/min of BK markedly attenuated hepatocellular damage. Magnification, 200×. (D) TUNEL quantification of liver specimens. BK infusion did not significantly reduce the number of apoptotic cells per field. Gastroenterology 2007 133, 2019-2028DOI: (10.1053/j.gastro.2007.09.023) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Effect of BK infusion on collagen deposition, myofibroblast accumulation, inflammatory cells, and gene expression. (A) Representative photomicrograph of Sirius red staining. Saline-infused CCl4-treated rats showed a marked bridging fibrosis throughout the parenchyma. BK infusion markedly attenuated fibrosis development. Magnification, 40×. (B) Morphometric quantification of positive area for Sirius red staining. (C) Representative photomicrograph of α-SMA staining. CCl4-treated rats receiving saline showed a marked accumulation of α-SMA–positive cells that colocalized with areas of fibrosis. BK infusion reduced the accumulation of positive cells. Magnification, 40×. (D) Morphometric quantification of positive area for α-SMA–positive cells. (E) Representative photomicrograph of CD43 staining. CCl4-treated rats receiving saline showed an increase of infiltration of CD43-positive inflammatory cells scattered in the liver parenchyma (arrows). BK infusion did not effect the infiltration of CD43 cells. Magnification, 100×. (F) Quantification of positive CD43 cells per field. (G) Pro-collagen α-1(I) gene expression was increased markedly in CCl4-treated rats receiving saline. BK infusion reduced collagen expression. (H) TGF-β1 gene expression was increased markedly in CCl4-treated rats receiving saline, which was reduced by BK infusion. ANOVA analysis, P < .05. Posttest analysis, ##P < .01 or #P < .05 compared with rat infused with saline. *P < .05 compared with CCl4-treated rats infused with saline. BK was infused at low (0.1 ng/kg/min) and high (100 ng/kg/min) concentrations. Gastroenterology 2007 133, 2019-2028DOI: (10.1053/j.gastro.2007.09.023) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Effects of BK infusion on hepatocellular apoptosis in a Fas-stimulated mouse model. (A) Effects of BK on ALT and AST serum levels. ANOVA, P < .001; post-test, #P < .01 compared with control mice infused with saline. *P < .01 compared with Jo2-injected mice infused with saline. BK was infused at 100 ng/kg/min. (B) Representative photomicrographs of liver specimens stained with TUNEL. Magnification, 400×. (C) TUNEL quantification of liver specimens. BK infusion markedly attenuated the number of apoptotic cells per field. Kruskal–Wallis test, P < .01; post-test, #P < .01 vs saline; *P < .05 vs Jo2. Gastroenterology 2007 133, 2019-2028DOI: (10.1053/j.gastro.2007.09.023) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Effects of BK on cultured rat hepatocytes. (A) Primary rat hepatocytes were preincubated for 15 minutes with B1-receptor antagonist des-arg10-HOE-140 or B2-receptor antagonist HOE-140 and stimulated with BK (0.1 μmol/L) for 1 hour. Nuclear translocation of the NF-κB p65 subunit was assessed by Western blot of nuclear extracts. BK (0.1 μmol/L) increased p65 translocation to the nucleus, indicating an induction of NF-κB activity. B1-receptor antagonist did not have an effect on p65 translocation induced by BK, whereas the B2-receptor antagonist blocked the effects of BK. The constitutively activated transcription factor, Oct-1, was used as a protein loading control. Graph shows the densitometry quantification of p65 with respect to Oct-1 expression. (B) Primary rat hepatocytes were stimulated with BK (0.1 μmol/L) for 30 minutes. ERK, AKT, and JNK phosphorylation was assessed by Western blotting. BK induced ERK and AKT but not JNK phosphorylation in the absence of actinomycin D (Act) and tumor necrosis factor α (tnf-α). BK reduced JNK phosphorylation induced by TNF-α. Figures are representative of 3 independent experiments. Gastroenterology 2007 133, 2019-2028DOI: (10.1053/j.gastro.2007.09.023) Copyright © 2007 AGA Institute Terms and Conditions

Figure 6 Effects of BK on human HSCs. (A) BK induced a marked increase in [Ca2+]i. Incubation of cells with the B2-receptor antagonist HOE-140, but not the B1-receptor antagonist des-Arg10-HOE-140, prevented the increase of [Ca2+]i. ♦, BK 1 μmol/L; ■, BK 0.1 μmol/L; ▲, BK 0.01 μmol/L; ○, HOE-140 + BK 0.1 μmol/L; –, des-Arg10-HOE-140 + BK 0.1 μmol/L. (B) BK (0.1 μmol/L) stimulation reduced the expression of procollagen αI(I) and TGF-β1, but not TIMP-1. *P < .05 vs buffer. B2-receptor antagonist HOE-140, or B1-receptor antagonist des-Arg10-HOE-140 failed to block the effects of BK. ■, Collagen αI(I); , TGF-β1; , TIMP-1. (C) Representative zymography analysis of gelatinolytic activity in HSC supernatants. (D) BK (0.1 μmol/L) stimulated the activity of metalloproteinase 2 (mmp-2) that was quantified by a densitometry analysis. *P < .05 vs buffer. Gastroenterology 2007 133, 2019-2028DOI: (10.1053/j.gastro.2007.09.023) Copyright © 2007 AGA Institute Terms and Conditions